rs77283072 influences breast cancer susceptibility by regulating <em>CDKN2A</em> expression

He,Guang-Huan; Liu,Shao-Dong; Shi,Xiao-Qian; Chen,Ying; Su,Li; Shi,Qiao-Na; Sun,Chang

doi:10.3892/ol.2023.13662

rs77283072 influences breast cancer susceptibility by regulating CDKN2A expression

Authors:
- Guang-Huan He
- Shao-Dong Liu
- Xiao-Qian Shi
- Ying Chen
- Li Su
- Qiao-Na Shi
- Chang Sun
View Affiliations

Affiliations: College of Life Sciences, Shaanxi Normal University, Xi'an, Shaanxi 710119, P.R. China
Published online on: January 5, 2023 https://doi.org/10.3892/ol.2023.13662
Article Number: 76

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Breast cancer is the cancer type with the highest morbidity rates in women, and previous genome‑wide association studies (GWASs) have suggested that the single nucleotide polymorphism (SNP) rs1011970 is significantly associated with this disease. An analysis of data from the 1000 Genomes Project demonstrated that there is an SNP, rs77283072, in almost complete linkage disequilibrium with rs1011970, which should therefore present the same signal in a GWAS. However, the actual causal SNP and its associated underlying mechanism have yet to be elucidated. Therefore, the present study evaluated the role of rs77283072 in terms of its association with breast cancer. A dual‑luciferase assay was performed, which demonstrated that the two alleles of rs1011970 did not exhibit significantly different reporter gene activity. However, the A allele of rs77283072 exhibited a significant increase in relative luciferase activity compared with the G allele, which suggested that rs77283072 was the causal SNP for breast cancer. Chromosome conformation capture demonstrated that the enhancer containing rs77283072 interacted with the promoter of cyclin‑dependent kinase inhibitor 2A (CDKN2A). Furthermore, expression quantitative trait locus analysis demonstrated that the expression of CDKN2A was dependent on the genotype of rs77283072. Taken together, the findings of the present study provided novel insights into the mechanism underlying how the genetic variation in this locus was able to influence breast cancer susceptibility and further the treatment for this disease.

View Figures

View References

1	Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A and Bray F: Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 71:209–249. 2021. View Article : Google Scholar : PubMed/NCBI
2	Michailidou K, Beesley J, Lindstrom S, Canisius S, Dennis J, Lush MJ, Maranian MJ, Bolla MK, Wang Q and Shah M: Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer. Nat Genet. 47:373–380. 2015. View Article : Google Scholar : PubMed/NCBI
3	Turnbull C, Ahmed S, Morrison J, Pernet D, Renwick A, Maranian M, Seal S, Ghoussaini M, Hines S, Healey CS, et al: Genome-wide association study identifies five new breast cancer susceptibility loci. Nat Genet. 42:504–507. 2010. View Article : Google Scholar : PubMed/NCBI
4	Fehringer G, Kraft P, Pharoah PD, Eeles RA, Chatterjee N, Schumacher FR, Schildkraut JM, Lindström S, Brennan P, Bickeböller H, et al: Cross-cancer genome-wide analysis of lung, ovary, breast, prostate, and colorectal cancer reveals novel pleiotropic associations. Cancer Res. 76:5103–5114. 2016. View Article : Google Scholar : PubMed/NCBI
5	The 1000 Genomes Project Consortium, . A global reference for human genetic variation. Nature. 526:68–74. 2015. View Article : Google Scholar : PubMed/NCBI
6	Li YK, Zhang XX, Yang Y, Gao J, Shi Q, Liu SD, Fu WP and Sun C: Convergent evidence supports TH2LCRR as a novel asthma susceptibility gene. Am J Respir Cell Mol Biol. 66:283–292. 2022. View Article : Google Scholar : PubMed/NCBI
7	Li X, Xu X, Fang J, Wang L, Mu Y, Zhang P, Yao Z, Ma Z and Liu Z: Rs2853677 modulates snail1 binding to the TERT enhancer and affects lung adenocarcinoma susceptibility. Oncotarget. 7:37825–37838. 2016. View Article : Google Scholar : PubMed/NCBI
8	Almeida R, Ricano-Ponce I, Kumar V, Deelen P, Szperl A, Trynka G, Gutierrez-Achury J, Kanterakis A, Westra HJ, Franke L, et al: Fine mapping of the celiac disease-associated LPP locus reveals a potential functional variant. Hum Mol Genet. 23:2481–2489. 2014. View Article : Google Scholar : PubMed/NCBI
9	Hagege H, Klous P, Braem C, Splinter E, Dekker J, Cathala G, de Laat W and Forné T: Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nat Protoc. 2:1722–1733. 2007. View Article : Google Scholar : PubMed/NCBI
10	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(−Delta Delta C(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
11	Pickrell JK, Marioni JC, Pai AA, Degner JF, Engelhardt BE, Nkadori E, Veyrieras JB, Stephens M, Gilad Y and Pritchard JK: Understanding mechanisms underlying human gene expression variation with RNA sequencing. Nature. 464:768–772. 2010. View Article : Google Scholar : PubMed/NCBI
12	Langmead B and Salzberg SL: Fast gapped-read alignment with Bowtie 2. Nat Methods. 9:357–359. 2012. View Article : Google Scholar : PubMed/NCBI
13	Roberts A and Pachter L: Streaming fragment assignment for real-time analysis of sequencing experiments. Nat Methods. 10:71–73. 2013. View Article : Google Scholar : PubMed/NCBI
14	Nie L, Vazquez AE and Yamoah EN: Identification of transcription factor-DNA interactions using chromatin immunoprecipitation assays. Methods Mol Biol. 493:311–321. 2009. View Article : Google Scholar : PubMed/NCBI
15	Li XX, Peng T, Gao J, Feng JG, Wu DD, Yang T, Zhong L, Fu WP and Sun C: Allele-specific expression identified rs2509956 as a novel long-distance cis-regulatory SNP for SCGB1A1, an important gene for multiple pulmonary diseases. Am J Physiol Lung Cell Mol Physiol. 317:L456–L463. 2019. View Article : Google Scholar : PubMed/NCBI
16	Zhang X, Gamble MJ, Stadler S, Cherrington BD, Causey CP, Thompson PR, Roberson MS, Kraus WL and Coonrod SA: Genome-wide analysis reveals PADI4 cooperates with Elk-1 to activate c-Fos expression in breast cancer cells. PLoS Genet. 7:e10021122011. View Article : Google Scholar : PubMed/NCBI
17	Sun C, Southard C, Witonsky DB, Kittler R and Di Rienzo A: Allele-specific down-regulation of RPTOR expression induced by retinoids contributes to climate adaptations. PLoS Genet. 6:e10011782010. View Article : Google Scholar : PubMed/NCBI
18	Shi Q, Yao XY, Wang HY, Li YJ, Zhang XX and Sun C: Breast cancer-associated SNP rs72755295 is a cis-regulatory variation for human EXO1. Genet Mol Biol. 45:e202104202022. View Article : Google Scholar : PubMed/NCBI
19	Feng J, Liu T, Qin B, Zhang Y and Liu XS: Identifying ChIP-seq enrichment using MACS. Nat Protoc. 7:1728–1740. 2012. View Article : Google Scholar : PubMed/NCBI
20	Calo E and Wysocka J: Modification of enhancer chromatin: What, how, and why? Mol Cell. 49:825–837. 2013. View Article : Google Scholar : PubMed/NCBI
21	Serra S and Chetty R: p16. J Clin Pathol. 71:853–858. 2018. View Article : Google Scholar : PubMed/NCBI
22	Liggett WH Jr and Sidransky D: Role of the p16 tumor suppressor gene in cancer. J Clin Oncol. 16:1197–1206. 1998. View Article : Google Scholar : PubMed/NCBI
23	Serrano M: The tumor suppressor protein p16INK4a. Exp Cell Res. 237:7–13. 1997. View Article : Google Scholar : PubMed/NCBI
24	Zhang Y, Xiong Y and Yarbrough WG: ARF promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus deletion impairs both the Rb and p53 tumor suppression pathways. Cell. 92:725–734. 1998. View Article : Google Scholar : PubMed/NCBI
25	Pomerantz J, Schreiber-Agus N, Liegeois NJ, Silverman A, Alland L, Chin L, Potes J, Chen K, Orlow I, Lee HW, et al: The Ink4a tumor suppressor gene product, p19Arf, interacts with MDM2 and neutralizes MDM2′s inhibition of p53. Cell. 92:713–723. 1998. View Article : Google Scholar : PubMed/NCBI
26	Li J, Poi MJ and Tsai MD: Regulatory mechanisms of tumor suppressor P16(INK4A) and their relevance to cancer. Biochemistry. 50:5566–5582. 2011. View Article : Google Scholar : PubMed/NCBI
27	Schumacher FR, Al Olama AA, Berndt SI, Benlloch S, Ahmed M, Saunders EJ, Dadaev T, Leongamornlert D, Anokian E, Cieza-Borrella C, et al: Association analyses of more than 140,000 men identify 63 new prostate cancer susceptibility loci. Nat Genet. 50:928–936. 2018. View Article : Google Scholar : PubMed/NCBI